Scientific output has never been higher, yet truly disruptive discoveries appear to be declining. A look at why breakthrough science is...
Niche crafted a strategic communications plan for ApaTech's synthetic bone graft portfolio, translating preclinical science into compelling manuscripts, regulatory documents and conference publications ahead of its $330 million acquisition.


















